Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.25 CHF | +0.42% | -5.35% | +46.46% |
Mar. 19 | Newron Pharmaceuticals S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 19 | Transcript : Newron Pharmaceuticals S.p.A., 2023 Earnings Call, Mar 19, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+46.46% | 147M | |
-4.89% | 85.08B | |
+2.11% | 40.14B | |
-25.74% | 28.37B | |
+51.96% | 24.07B | |
-6.17% | 17.24B | |
-31.09% | 13.85B | |
-6.58% | 12.29B | |
-16.04% | 11.95B | |
-4.19% | 8.02B |
- Stock Market
- Equities
- NWRN Stock
- News Newron Pharmaceuticals S.p.A.
- Newron Pharmaceuticals S.p.A. announced that it has received €40 million in funding from European Investment Bank, Investment Arm